UTMB Health @utmbhealth · 03 Sep 2026
UTMB is preparing to enroll its first patient in a Phase II trial of FG-001, an imaging agent designed to help neurosurgeons identify aggressive brain tumors during surgery. Dr. Pablo Valdes and his team will lead the study. Read more: https://t.co/L3b64jIGNb https://t.co/rliqfp6Tge
256Views
2Likes
1Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
0.79×vs this author's median324 views is typical
20Percentile for this authorof 5 recent posts
0.09×vs 10K–100K median2 747 views is typical
2.53%Reachviews ÷ followers
1.17%Engagement rateof viewers reacted